Wall Street analysts predict that HealthStream, Inc. (NASDAQ:HSTM) will post sales of $62.37 million for the current fiscal quarter, Zacks reports. Five analysts have made estimates for HealthStream’s earnings, with the lowest sales estimate coming in at $61.10 million and the highest estimate coming in at $63.92 million. HealthStream reported sales of $58.74 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 6.2%. The firm is scheduled to report its next earnings results on Tuesday, February 20th.

According to Zacks, analysts expect that HealthStream will report full-year sales of $62.37 million for the current financial year, with estimates ranging from $246.00 million to $248.15 million. For the next year, analysts expect that the firm will post sales of $268.72 million per share, with estimates ranging from $263.56 million to $272.62 million. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover HealthStream.

HealthStream (NASDAQ:HSTM) last posted its quarterly earnings data on Monday, October 23rd. The technology company reported $0.08 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.05 by $0.03. HealthStream had a net margin of 2.36% and a return on equity of 2.46%. The company had revenue of $63.60 million for the quarter, compared to the consensus estimate of $62.48 million. During the same period last year, the company earned $0.04 earnings per share. The firm’s revenue was up 8.9% compared to the same quarter last year.

HSTM has been the topic of a number of recent research reports. Robert W. Baird lowered their price objective on shares of HealthStream from $30.00 to $28.00 and set an “outperform” rating on the stock in a report on Wednesday, October 25th. ValuEngine upgraded shares of HealthStream from a “sell” rating to a “hold” rating in a report on Wednesday, January 3rd. Zacks Investment Research upgraded shares of HealthStream from a “hold” rating to a “strong-buy” rating and set a $27.00 price objective on the stock in a report on Wednesday, October 25th. Canaccord Genuity reiterated a “hold” rating and issued a $25.00 price objective on shares of HealthStream in a report on Monday, October 23rd. Finally, Needham & Company LLC downgraded shares of HealthStream from a “buy” rating to a “hold” rating in a report on Wednesday, October 25th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $24.83.

HealthStream (NASDAQ:HSTM) traded down $0.13 during midday trading on Thursday, hitting $24.27. 86,216 shares of the stock were exchanged, compared to its average volume of 102,903. HealthStream has a 12 month low of $20.60 and a 12 month high of $31.53. The firm has a market capitalization of $774.12, a P/E ratio of 134.84, a PEG ratio of 5.12 and a beta of 0.91.

A number of institutional investors and hedge funds have recently modified their holdings of HSTM. UBS Asset Management Americas Inc. bought a new stake in HealthStream during the second quarter worth about $205,000. BNP Paribas Arbitrage SA lifted its holdings in shares of HealthStream by 53.9% during the second quarter. BNP Paribas Arbitrage SA now owns 8,131 shares of the technology company’s stock valued at $214,000 after purchasing an additional 2,849 shares in the last quarter. Municipal Employees Retirement System of Michigan lifted its holdings in shares of HealthStream by 59.5% during the third quarter. Municipal Employees Retirement System of Michigan now owns 9,570 shares of the technology company’s stock valued at $224,000 after purchasing an additional 3,570 shares in the last quarter. GSA Capital Partners LLP bought a new position in shares of HealthStream during the third quarter valued at $237,000. Finally, Virginia Retirement Systems ET AL bought a new position in shares of HealthStream during the third quarter valued at $264,000. Institutional investors and hedge funds own 74.32% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Zacks: Analysts Expect HealthStream, Inc. (HSTM) Will Post Quarterly Sales of $62.37 Million” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2018/01/14/zacks-analysts-expect-healthstream-inc-hstm-will-post-quarterly-sales-of-62-37-million.html.

HealthStream Company Profile

HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.

Get a free copy of the Zacks research report on HealthStream (HSTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related stocks with our FREE daily email newsletter.